Krynica Vitamin Statistics

Total Valuation

Krynica Vitamin has a market cap or net worth of PLN 115.90 million. The enterprise value is 156.67 million.

Market Cap	115.90M
Enterprise Value	156.67M

Important Dates

The last earnings date was Monday, May 26, 2025.

Earnings Date	May 26, 2025
Ex-Dividend Date	Jul 10, 2025

Share Statistics

Krynica Vitamin has 12.25 million shares outstanding. The number of shares has decreased by -0.18% in one year.

Current Share Class	12.25M
Shares Outstanding	12.25M
Shares Change (YoY)	-0.18%
Shares Change (QoQ)	+0.73%
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	1.92%
Float	1.61M

Valuation Ratios

The trailing PE ratio is 8.11.

PE Ratio	8.11
Forward PE	n/a
PS Ratio	0.30
PB Ratio	1.22
P/TBV Ratio	1.26
P/FCF Ratio	4.55
P/OCF Ratio	3.17
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.53, with an EV/FCF ratio of 6.16.

EV / Earnings	10.96
EV / Sales	0.41
EV / EBITDA	4.53
EV / EBIT	7.58
EV / FCF	6.16

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.43.

Current Ratio	0.87
Quick Ratio	0.45
Debt / Equity	0.43
Debt / EBITDA	1.18
Debt / FCF	1.61
Interest Coverage	6.58

Financial Efficiency

Return on equity (ROE) is 16.28% and return on invested capital (ROIC) is 9.30%.

Return on Equity (ROE)	16.28%
Return on Assets (ROA)	5.78%
Return on Invested Capital (ROIC)	9.30%
Return on Capital Employed (ROCE)	18.22%
Revenue Per Employee	1.15M
Profits Per Employee	42,533
Employee Count	336
Asset Turnover	1.72
Inventory Turnover	7.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.84% in the last 52 weeks. The beta is -0.54, so Krynica Vitamin's price volatility has been lower than the market average.

Beta (5Y)	-0.54
52-Week Price Change	-20.84%
50-Day Moving Average	9.65
200-Day Moving Average	9.48
Relative Strength Index (RSI)	44.40
Average Volume (20 Days)	1,038

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Krynica Vitamin had revenue of PLN 385.47 million and earned 14.29 million in profits. Earnings per share was 1.17.

Revenue	385.47M
Gross Profit	65.24M
Operating Income	20.68M
Pretax Income	16.11M
Net Income	14.29M
EBITDA	34.55M
EBIT	20.68M
Earnings Per Share (EPS)	1.17

Full Income Statement

Balance Sheet

The company has 89,000 in cash and 40.86 million in debt, giving a net cash position of -40.77 million or -3.33 per share.

Cash & Cash Equivalents	89,000
Total Debt	40.86M
Net Cash	-40.77M
Net Cash Per Share	-3.33
Equity (Book Value)	94.95M
Book Value Per Share	7.75
Working Capital	-14.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 36.55 million and capital expenditures -11.11 million, giving a free cash flow of 25.45 million.

Operating Cash Flow	36.55M
Capital Expenditures	-11.11M
Free Cash Flow	25.45M
FCF Per Share	2.08

Full Cash Flow Statement

Margins

Gross margin is 16.92%, with operating and profit margins of 5.36% and 3.71%.

Gross Margin	16.92%
Operating Margin	5.36%
Pretax Margin	4.18%
Profit Margin	3.71%
EBITDA Margin	8.96%
EBIT Margin	5.36%
FCF Margin	6.60%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.79%.

Dividend Per Share	0.27
Dividend Yield	2.79%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.18%
Shareholder Yield	2.97%
Earnings Yield	12.33%
FCF Yield	21.96%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Krynica Vitamin has an Altman Z-Score of 2.66. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.66
Piotroski F-Score	n/a